Autopsy report · NCT05892211
LINE-1 and Alu Methylation Levels Among Middle Aged Women With Low Cardiovascular Risk Profile in Respect of Menopausal Hot Flashes
Cause of deathStaffing, sites or logistics
“The university has relocated to a new place due to earthquake.”
Life of this trial
- Registered 2 years 5 months after it had already started.
- Suspended: paused, and may or may not restart.
- 30 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Sponsor
- Istanbul University - Cerrahpasa
- Sponsor type
- University, hospital or other
- Conditions
- Hot Flashes; Sleep; Menopause; Cardiovascular Diseases; Epigenetics; DNA Methylation
- Interventions
- Polysomnography; Skin conductance; ALU and LINE-1 DNA methylation analysis; The Menopause-Specific Quality of Life Questionnaire (MENQOL); Pittsburgh Sleep Quality Index (PSQI)
- Participants
- 30 (planned, not actual)
- Sites
- 1
- Countries
- Turkey (Türkiye)
Trials that died the same way
- Behavioral Self-Help Intervention for Pediatric Atopic Dermatitis and Eczema Patients
“moved to new institution”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.